Organization (Academic)
Wilfrid Laurier University
ClinicalTrials.gov lists Wilfrid Laurier University as lead sponsor of 15 trials. It has 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Wilfrid Laurier University: 15 lead-sponsored trials and 1 legal-entity registration.
Disease areas (9)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Parkinson Disease | 4 |
| Anxiety Disorders | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Back Pain | 1 |
| Flatfoot | 1 |
Showing 5 of 9 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 3 |
| 2014 | 4 |
| 2013 | 2 |
| 2011 | 1 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (1)
| Drug | Trials |
|---|---|
| Lactate | 1 |
Journals published in (34)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Canadian journal of psychiatry. Revue canadienne de psychiatrie | 2 |
| Implementation science : IS | 2 |
| International journal of environmental research and public health | 2 |
| Spine | 2 |
| American journal of industrial medicine | 1 |
Showing 5 of 34 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 3 | 0 | 2001-09-04 |
Organization relationships (6)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Universidade de Brasília | Co sponsors trial with | 1 |
| University of Ottawa | Co sponsors trial with | 1 |
| Canadian College of Naturopathic Medicine | Co sponsors trial with | 1 |
| Kinyinya Health Centre | Co sponsors trial with | 1 |
| Global Benefit Canada | Co sponsors trial with | 1 |
Showing 5 of 6 relationships.
Latest dated events (23)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-06-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-01-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-11-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-05-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 23 events.
Biomarker capability evidence (7)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CD4 | Trial collaborator | Named in trial inclusion criteria |
| CD4 | Trial collaborator | Primary endpoint in a Phase 3 trial |
| CYP3A4 | Trial sponsor | Named in trial inclusion criteria |
| GNAQ | Trial sponsor | Named in trial inclusion criteria |
| CD4 | Trial collaborator | Mentioned in trial text |
Showing 5 of 7 evidence rows.
Biomarkers this organization publishes on (37)
Shown in this order: most publications first.
Showing 5 of 37 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.